Xeris Biopharma Holdings Inc. buy HC Wainwright
Start price
31.05.24
/
50%
€2.11
Target price
31.05.25
€5.51
Performance (%)
21.50%
Price
27.09.24
€2.57
Summary
This prediction is currently active. The BUY prediction by HC_Wainwright currently has a performance of 21.50%. This prediction currently runs until 31.05.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Xeris Biopharma Holdings Inc. | - | - |
iShares Core DAX® | 1.518% | 3.456% |
iShares Nasdaq 100 | 1.240% | 2.983% |
iShares Nikkei 225® | 2.808% | 2.743% |
iShares S&P 500 | 0.403% | 2.187% |
Comments by HC_Wainwright for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for XERS provided by MarketBeat
Stopped prediction by HC_Wainwright for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€2.37
15.08.24
15.08.24
€5.47
15.08.25
15.08.25
8.18%
27.09.24
27.09.24
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€2.16
10.08.23
10.08.23
€5.44
10.08.24
10.08.24
-0.46%
11.08.24
11.08.24
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€1.15
09.03.23
09.03.23
€5.67
09.03.24
09.03.24
91.14%
10.03.24
10.03.24